Feb. 2, 2023 – “There’s still a lot to be learned for identifying the underlying cause of addiction and being able to address that with a specific target,” he said. “That limits the shots on goal. If you look at the number of targets, there just aren’t that many at all. If there were, maybe that would incentivize investors to get behind more of the novel targets. But we just don’t see many there.”
The report suggests that, even though U.S. addiction deaths are hovering around their all-time high, drug companies and the investors who back them are unlikely to provide solutions anytime soon.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…